Konstantin Benno Bräutigam
pathologop.bsky.social
Konstantin Benno Bräutigam
@pathologop.bsky.social
Research Fellow at @icr.ac.uk

Board-certified histopathologist, MD
BSc in Economics

Science enthusiast and pathomechanist.
Pinned
Happy to co-chair the #Pathology Working Group of the European Society for Spatial Biology (ESSB) e.V. #ESSB with Francesca Maria Bosisio, MD, PhD and Christian Matek, MD!

Please join the group and let us promote science together!

Link to join: docs.google.com/forms/d/e/1F...
ESSB Working Group survey
Please enter your information to join an ESSB working group
docs.google.com
Reposted by Konstantin Benno Bräutigam
Calling cancer data scientists! 📊 💽 🧮
We have a number of open positions in our core facility @icr.ac.uk These are bioinformatician staff scientist like roles to work on exciting single cell, spatial & other genomics data from across our Institute. A PhD is required. jobs.icr.ac.uk/vacancies/13...
Data Scientist in Sutton | The Institute of Cancer Research
View details and apply for this Data Scientist vacancy in Sutton. Salary : Salary range £39,805 to £53,500 (Dependent on experience ) Reporting to: Professor Trevor Gra...
jobs.icr.ac.uk
November 13, 2025 at 2:59 PM
Fantastatic paper from my host lab looking at the immune-genome intersection in the "big bang" of #CRC!
November 5, 2025 at 5:54 PM
Happy to co-chair the #Pathology Working Group of the European Society for Spatial Biology (ESSB) e.V. #ESSB with Francesca Maria Bosisio, MD, PhD and Christian Matek, MD!

Please join the group and let us promote science together!

Link to join: docs.google.com/forms/d/e/1F...
ESSB Working Group survey
Please enter your information to join an ESSB working group
docs.google.com
October 16, 2025 at 2:39 PM
Reposted by Konstantin Benno Bräutigam
Great to see some exciting applications of #MuSpAn in action in @pathologop.bsky.social's talk at #ESSB2025 today!

Come and say hi if you'd like to find out more about the software, or to have a chat about how MuSpAn might be able to help with your data analysis :) #EMBLSpatialBiology
October 15, 2025 at 9:30 AM
Reposted by Konstantin Benno Bräutigam
CAR T therapy has seen great effectiveness in liquid tumors, but little in solid tumors (e.g. ovarian cancer).

Here we developed hyper-migratory CAR TV cells to infiltrate en masse ovarian tumors. (Left: control CAR T cells; right CAR TV cells).

Read this here: www.biorxiv.org/content/10.1...
October 5, 2025 at 4:48 PM
Reposted by Konstantin Benno Bräutigam
Cancer is an evolutionary disease, but does knowing a cancer’s evolutionary past help predict its future? Out today in @nature, we learnt the evolution of 2000 lymphoid cancers and found it was highly correlated with clinical outcomes! (1/7)
rdcu.be/eFrrc
Fluctuating DNA methylation tracks cancer evolution at clinical scale
Nature - Cancer evolutionary dynamics are quantitatively inferred using a method, EVOFLUx, applied to fluctuating DNA methylation.
rdcu.be
September 10, 2025 at 4:17 PM
Reposted by Konstantin Benno Bräutigam
Studying cancer evolution needs multi-region or single cell seq for phylogenetics, right? Amazingly (I think!) we found single-sample bulk methylation suffices, via analysis of "fluctuating methylation". In @nature.com today led by brilliant @calumgabbutt.bsky.social www.nature.com/articles/s41...
Fluctuating DNA methylation tracks cancer evolution at clinical scale - Nature
Cancer evolutionary dynamics are quantitatively inferred using a method, EVOFLUx, applied to fluctuating DNA methylation.
www.nature.com
September 10, 2025 at 3:21 PM
Communication in pathology, the power of word. Excellent keynote at #ecp2025 in #vienna!
September 7, 2025 at 10:29 AM
Reposted by Konstantin Benno Bräutigam
So accurate, it hurts
Journals in August
August 22, 2025 at 3:15 PM
Fantastic workshop on the ecology and #evolution of cancer #EBEC2025! So thrilled and proud to have been part of it! @sangerinstitute.bsky.social #cambridge
July 4, 2025 at 12:48 PM
Looking forward to the "Evolutionary Biology and Ecology of Cancer" course in #Cambridge at the #wellcome genome campus! #genomics
June 30, 2025 at 10:22 AM
Reposted by Konstantin Benno Bräutigam
Tour de force from @melissabarroux.bsky.social on evolutionary and microenvironmental dynamics of oesophageal adenocarcinoma through neoadjuvant therapy

Published @natcancer.nature.com

Melissa is an outstanding new clinician scientist.. one to watch.

www.nature.com/articles/s43...

@icr.ac.uk
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinoma - Nature Cancer
Graham and colleagues analyzed locally advanced esophageal adenocarcinoma clinical trial patient samples and identified major changes in gene expression profiles and immune microenvironment compositio...
www.nature.com
May 15, 2025 at 5:20 PM
Reposted by Konstantin Benno Bräutigam
dATAC: our new method for simultaneous very high quality whole genome sequencing and chromatin accessibility profiling of single cells. We used dATAC to trace epigenome clonal evolution in colon cancer. Devised by the extraordinarily talented @maxmossner.bsky.social

www.biorxiv.org/content/10.1...
Single cell multi-omic whole genome sequencing and chromatin accessibility profiling reveals genome-epigenome coevolution in colorectal cancer
Epigenetic alterations co-evolve with genetic mutations to drive carcinogenesis and treatment response. Resolving genome-epigenome coevolution requires accurate multi-omic single cell measurement. Her...
www.biorxiv.org
April 23, 2025 at 3:42 PM
Reposted by Konstantin Benno Bräutigam
#pathsky
Excellent talk on pancreatic neuroendocrine neoplasms at the Spring Meeting of the Austrian Society for Pathology y Konstantin Bräutigam @pathologop.bsky.social #oegpath
March 15, 2025 at 9:59 AM
Happy to be part of "Immunocto", a massive immune cell database in a H&E/IF approach!

arxiv.org/abs/2406.02618
Immunocto: a massive immune cell database auto-generated for histopathology
With the advent of novel cancer treatment options such as immunotherapy, studying the tumour immune micro-environment (TIME) is crucial to inform on prognosis and understand potential response to ther...
arxiv.org
March 3, 2025 at 8:12 AM
⏰preprint alert⏰

I am very happy to share our recent preprint on targeting metabolism in Pancreatic Neuroendocrine Tumors via lactate transporters MCT1/4!

www.biorxiv.org/content/10.1...

Incredible amount of experimental work, many thanks to all contributors and especially to the seniors!
Dual inhibition of lactate transporters MCT1 and MCT4 in pancreatic neuroendocrine tumors targets metabolic heterogeneity and functional redundancy
Our current understanding of the metabolic landscape of pancreatic neuroendocrine tumors (PanNETs) is very limited. Such knowledge could lead the development of novel therapeutic strategies for subgro...
www.biorxiv.org
February 8, 2025 at 8:18 AM
Reposted by Konstantin Benno Bräutigam
Are you using #AI to analyse #Histopathology images?

A team of ICR researchers have created a glossary to help AI developers understand tumour histopathology.

They hope that this will speed up the development of AI algorithms for cancer research ⤵️

doi.org/10.1371/jour...
The tumour histopathology “glossary” for AI developers
The applications of artificial intelligence (AI) and deep learning (DL) are leading to significant advances in cancer research, particularly in analysing histopathology images for prognostic and treat...
doi.org
January 28, 2025 at 12:54 PM